Evidence map›Paper›PMID 39245901›Full record

ArticleThe Australian and New Zealand journal of psychiatry2025

The epidemiology of mental and substance use disorders in Australia 2020-22: Prevalence, socio-demographic correlates, severity, impairment and changes over time.

Tim Slade, Joshua Vescovi, Cath Chapman, Maree Teesson, Vikas Arya, Jane Pirkis, Meredith G Harris, Philip M Burgess, Damian Santomauro, Siobhan O'Dean and 2 more

Abstract read
In one paragraph

Article in The Australian and New Zealand journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Under-25s show the clearest post-2021 rebound in mental health: HILDA 2001-2024.The Australian and New Zealand journal of psychiatry · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Policy implications of the 2020-22 Australian study of mental health and wellbeing.The Australian and New Zealand journal of psychiatry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tim SladeThe Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, NSW, Australia.ORCID 0000-0002-1725-9188
Joshua VescoviThe Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, NSW, Australia.ORCID 0009-0007-0845-6204
Cath ChapmanThe Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, NSW, Australia.
Maree TeessonThe Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, NSW, Australia.ORCID 0000-0002-6744-463X
Vikas AryaCentre for Mental Health, The University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0002-0594-1526
Jane PirkisCentre for Mental Health, The University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0002-2538-4472
Meredith G HarrisSchool of Public Health, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0003-0096-729X
Philip M BurgessSchool of Public Health, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0001-7184-0363
Damian SantomauroSchool of Public Health, The University of Queensland, Brisbane, QLD, Australia.
Siobhan O'DeanThe Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, NSW, Australia.ORCID 0000-0002-5898-2065
Caley TappSchool of Public Health, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0002-2731-7345
Matthew SunderlandThe Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMental and substance use disorders are the leading causes of disability worldwide. Contemporary estimates of prevalence, severity and impairment are essential for service planning. This study provides estimates of prevalence, severity, impairment and demographic correlates of mental and substance use disorders in 2020-22 and changes in prevalence since 2007.

methodsData were from the two Australian National Surveys of Mental Health and Wellbeing conducted in 2020-22 (

resultsThe lifetime prevalence of any mental or substance use disorder in 2020-22 was 40.2%. The 12-month prevalence was 20.2% (mood disorder - 7.4%, anxiety disorder - 15.7% and substance use disorder - 3.1%). Mood disorders were associated with significant impairment. The prevalence of mental disorders has changed over time, with mood and anxiety disorders increasing and substance use disorders decreasing. These changes were most evident among young adults.

conclusionMental disorders are common in Australia. Impairment associated with mental disorders remains significant. Particular focus should be paid to young adults aged 16-25 years who have shown the largest increases in anxiety and mood disorder prevalence over the past 13 years.

Indexed as

Anxiety DisordersMental DisordersMood DisordersSubstance-Related DisordersAdolescentAdultAgedAustraliaFemaleHealth SurveysHumansMaleMiddle AgedPrevalenceSeverity of Illness IndexYoung AdultepidemiologyMental disordersprevalenceseveritysubstance use disorders

Identifiers

PMID39245901
PMCPMC12102513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.